You might experience some swelling, bruising, or redness in the treated area, but these symptoms are usually mild and disappear within a few days
doi: 10.1016/j.fertnstert.2005.03.064
Retatrutide (LY3437943), developed by Eli Lilly, is a once-weekly injectable GIP/GLP-1/glucagon triple receptor agonist
Ca Gluc, Vit B5 Dexpanthenol, MgCl, MTE 5, Vit B1 Thiamine, Vit B3 Niacinamide, Vit B2 Riboflavin, Zinc, Pyridoxine (B6), Selenium & Ascorbic acid
Ramos Perez JM, Kadia TM, Montalban-Bravo G, Benton CB, Faderl S, Sasaki K, Naqvi K, Cortes JE, MD, Daver NG, DiNardo CD, Jabbour E, Borthakur GM, Al Azzawi H, Pemmaraju N, Konopleva MY, Pierce SA, Jain N, Ohanian M, Garcia-Manero G, Andreeff M , Kantarjian HM, Ravandi F, Alvarado Y